weight loss surgery vs glp-1 Metabolic and agonists | Blog Choosing Between Weight Loss Medications
Description
Immunogenicity assessments, including the detection of anti-drug antibodies and neutralizing antibodies, are essential for ensuring drug safety and effectiveness
In concert, these results define a new scenario of action for incretin-based therapy that may involve the adipo-insular axis, linking the weight lowering competence with the sustained protection of -cells from diabetogenic stressors
Published in the New England Journal of Medicine in 2025, this Phase 3 study enrolled 610 Chinese adults with obesity or overweight accompanied by at least one weight-related comorbidity
Deng, G
